Answers are grounded in this paper and cite their sources.
Aim: To explore associations of whole-tumor and habitat radiomics with study-documented Clonorchis sinensis (Cs) status in hepatocellular carcinoma. Methods: This retrospective study included 161 patients: 77 with computed tomography (CT) and 84 with magnetic resonance (MR) imaging. A patient-level split yielded 128 training and 33 internal holdout patients. Modality-specific habitats were constructed from training voxels with patient-balanced sampling. An ExtraTrees model combined whole-tumor features and label-invariant habitat summaries. Modality-only and MR acquisition-only controls were compared on the same holdout. Additional MR analyses examined resampling and acquisition sensitivity. Case-level infection ascertainment and clinical covariates were unavailable. Results: Holdout area under the receiver operating characteristic curve (AUROC) was 0.833 [95% confidence interval (CI): 0.683-0.955]. The model exceeded the modality-only control (AUROC 0.643; paired difference +0.190, 95%CI: 0.048-0.339; P = 0.008). The pooled-model MR subgroup did not outperform the acquisition control (AUROC 0.846 vs. 0.885; difference -0.038, 95%CI: -0.232-0.115; P = 0.742). Among 90 MR development patients, AUROC from probabilities averaged across three nested cross-validation repeats was 0.854 (95%CI: 0.765-0.926); 14 patients overlapped the original holdout. Restriction to shared acquisition support yielded AUROC 0.684 in 34 patients. Conclusion: Radiomics showed exploratory associations with study-documented Cs status. Acquisition coupling, endpoint uncertainty, unmeasured clinical confounding and reused evaluation data prevent interpretation as infection diagnosis or independent validation.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: